A Target Antigen–Based Approach to the Classification of Membranous Nephropathy
| Autor: | Casal Moura Marta, Sanjeev Sethi, Julie A. Vrana, Samar M. Said, John C. Lieske, Shane A. Bobart, An S. De Vriese, Samih H. Nasr, Mariam P. Alexander, Callen D. Giesen, Fernando C. Fervenza, Shahrzad Tehranian |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
Male Pathology medicine.medical_specialty Anti-nuclear antibody Disease N-Acetylglucosaminyltransferases Malignancy Glomerulonephritis Membranous Severity of Illness Index Antigen Membranous nephropathy Humans Medicine Antigens Neural Cell Adhesion Molecules Pathological Aged Autoantibodies business.industry Receptors Phospholipase A2 Retrospective cohort study General Medicine Middle Aged Cadherins medicine.disease Immunohistochemistry Protocadherins Cohort Female Thrombospondins business |
| Zdroj: | Mayo Clinic Proceedings. 96:577-591 |
| ISSN: | 0025-6196 |
| DOI: | 10.1016/j.mayocp.2020.11.028 |
| Popis: | Objective To describe the clinical and pathological phenotype of membranous nephropathy (MN) associated with M-type-phospholipase–A2-receptor (PLA2R), thrombospondin-type-1-domain-containing-7A (THSD7A), semaphorin 3B (SEMA3B), neural-epidermal-growth-factor-like-1-protein (NELL-1), protocadherin 7 (PCDH7), exostosin 1/exostosin 2 (EXT1/EXT2) and neural cell adhesion molecule 1 (NCAM-1) as target antigens. Methods A retrospective cohort of 270 adult patients with biopsy-proven MN diagnosed between January 2015 and April 2020 was classified as PLA2R-, THSD7A-, SEMA3B-, NELL-1–, PCDH7-, EXT1/EXT2-, NCAM-1–associated or septuple-negative MN using serologic tests, immunostaining, and/or mass spectrometry. Clinical, biochemical, pathologic, and follow-up data were systematically abstracted from the medical records, including disease activity of conditions traditionally associated with MN and occurring within 5 years of MN diagnosis. Results Patients with PLA2R-associated MN were predominantly middle-aged white men without associated disease. The presence of associated disease did not affect the clinical and pathologic characteristics of PLA2R-associated MN, suggesting that they were coincidental rather than causally linked. THSD7A-, NELL-1–, PCDH7-, and NCAM-1–associated MN were rare and SEMA3B-associated MN was not discovered in our cohort. EXT1/EXT2-associated MN was primarily diagnosed in younger women with active systemic autoimmunity. A significant proportion of septuple-negative patients had associated malignancy or systemic autoimmunity. Conclusion The widely used distinction between primary and secondary MN has limitations. We propose a refined terminology that combines the target antigen and associated disease to better classify MN and guide clinical decision making. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|